The efficacy of Herceptin therapies is influenced by the expression of other erbB receptors, their ligands and the activation of downstream signalling proteins

Bradley L. Smith(Cell Signaling Technology (United States)), Sarah Bacus(Tennessee Oncology)
British Journal of Cancer
August 10, 2004
Cited by 86


Related Papers